INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 180 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,224,800 | +2001.7% | 120,000 | +1153.8% | 0.02% | +1600.0% |
| Q2 2023 | $105,855 | +109.5% | 9,571 | +154.3% | 0.00% | – |
| Q1 2023 | $50,537 | +2.2% | 3,763 | -5.9% | 0.00% | – |
| Q4 2022 | $49,455 | -80.2% | 3,998 | -60.5% | 0.00% | -100.0% |
| Q4 2020 | $250,000 | -91.6% | 10,110 | -65.8% | 0.00% | -91.7% |
| Q4 2018 | $2,982,000 | +238.1% | 29,580 | +323.8% | 0.01% | +140.0% |
| Q3 2018 | $882,000 | +21.0% | 6,980 | -19.7% | 0.01% | +25.0% |
| Q2 2018 | $729,000 | +219.7% | 8,688 | +122.6% | 0.00% | +100.0% |
| Q4 2017 | $228,000 | -77.1% | 3,903 | -77.3% | 0.00% | -77.8% |
| Q3 2017 | $997,000 | – | 17,170 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |